ALMR
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. (ALMR) has 7 SEC Form 4 filings (44 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Apr 22, 2026.
Insiders have net bought $8.0M over the trailing 6 months. The largest single insider purchase in this window was $4.0M by Insider Naclerio Nicholas on Apr 20, 2026.
- Industry:Biotechnology
- CEO:Justin J. McAnear
- Employees:222
- HQ:Fremont, CA, US
- IPO:2026-04-17
Insider Buying
$8.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.8B
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Naclerio NicholasFirst filing | Insider | Purchase | 235,294 | $4.0M | Apr 20 | SEC ↗ |
Illumina Innovation Fund II GP, L.L.C.First filing | 10% Owner | Purchase | 235,294 | $4.0M | Apr 20 | SEC ↗ |
Related companies
Alamar Biosciences, Inc. is in the Healthcare sector.